MTHFR and hyperinsulinemic hypoglycemia, familial, 4: We envisage that small molecules targeting the MTHFRFLSAH conformer, through binding to site 1, could be a therapeutic avenue for MTHFR deficiency where the residual enzyme could be dis-inhibited.